China National Medicines Corp Ltd Capital Reinvestment Ratio
China National Medicines Corp Ltd capital reinvestment ratio. China National Medicines Corp Ltd (600511) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥382.74 Million) in capital expenditures (CN¥13.23 Million). Check China National Medicines Corp Ltd (600511) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China National Medicines Corp Ltd (2002–2024)
Capital reinvestment ratio of China National Medicines Corp Ltd from 2002 to 2024. This chart tracks China National Medicines Corp Ltd's Capital Reinvestment Ratio across 22 annual periods. Also explore China National Medicines Corp Ltd net asset momentum to track the company's year-over-year net asset growth rate.
China National Medicines Corp Ltd Capital Reinvestment Ratio by Year (2002–2024)
China National Medicines Corp Ltd capital reinvestment ratio by year from 2002 to 2024. For the full cash flow conversion analysis, see China National Medicines Corp Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | CN¥1.66 Billion | CN¥130.77 Million | ▲ +48.1% |
| 2023 | 0.05x | CN¥2.73 Billion | CN¥145.12 Million | ▼ -1.8% |
| 2022 | 0.05x | CN¥2.40 Billion | CN¥129.78 Million | ▲ +11.6% |
| 2021 | 0.05x | CN¥1.96 Billion | CN¥95.07 Million | ▼ -8.5% |
| 2020 | 0.05x | CN¥1.30 Billion | CN¥69.05 Million | ▲ +9.9% |
| 2019 | 0.05x | CN¥1.78 Billion | CN¥85.72 Million | ▼ -64.2% |
| 2018 | 0.13x | CN¥981.65 Million | CN¥132.46 Million | ▲ +97.9% |
| 2017 | 0.07x | CN¥1.07 Billion | CN¥73.25 Million | ▲ +1.1% |
| 2016 | 0.07x | CN¥591.25 Million | CN¥39.88 Million | ▼ -56.6% |
| 2015 | 0.16x | CN¥440.29 Million | CN¥68.47 Million | ▼ -77.0% |
| 2014 | 0.68x | CN¥218.94 Million | CN¥148.22 Million | ▲ +3.3% |
| 2013 | 0.66x | CN¥185.56 Million | CN¥121.66 Million | ▼ -28.2% |
| 2012 | 0.91x | CN¥185.87 Million | CN¥169.65 Million | ▲ +1105.7% |
| 2010 | 0.08x | CN¥318.21 Million | CN¥24.09 Million | ▼ -13.5% |
| 2009 | 0.09x | CN¥255.18 Million | CN¥22.33 Million | ▲ +17.2% |
| 2008 | 0.07x | CN¥217.10 Million | CN¥16.21 Million | ▼ -31.1% |
| 2007 | 0.11x | CN¥79.48 Million | CN¥8.61 Million | ▼ -44.7% |
| 2006 | 0.20x | CN¥121.50 Million | CN¥23.81 Million | ▼ -56.2% |
| 2005 | 0.45x | CN¥92.20 Million | CN¥41.24 Million | ▼ -74.7% |
| 2004 | 1.77x | CN¥49.18 Million | CN¥87.08 Million | ▼ -99.0% |
| 2003 | 172.79x | CN¥526.15K | CN¥90.92 Million | ▲ +18401.7% |
| 2002 | 0.93x | CN¥15.19 Million | CN¥14.19 Million | — |